Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Alan Partin MD, PhD

Alan W. Partin MD, PhD

Director, Department of Urology, Brady Urological Institute; The Jakurski Family Director and Professor, Urologist-in-Chief, Johns Hopkins Hospital, Baltimore, Maryland

Biographical Sketch:

Alan W. Partin, MD, PhD, is the author or co-author of more than 600 scientific articles, serves on numerous editorial boards, served as editor-in-chief of Urology (1997–2007), and is currently an editor of the Campbell-Walsh-Wein urology text. He has been honored with many awards, including the Hopkins Young Investigators Award, the Pfizer Scholars in Urology award, and the Gold Cystoscope award. In 2004, Dr. Partin was named Director of the Department of Urology at the Brady Urological Institute and, in 2005, Urologist-in-Chief of the Johns Hopkins Hospital.

Dr. Partin is an expert in assessing prognosis and making predictions for men with prostate cancer. Dr. Partin’s laboratories and clinical and surgical interests focus on developing and testing new and existing methods for predicting the aggressiveness of prostate cancers so that rational treatment decisions can be made by both patients and physicians.

Dr. Partin received his undergraduate degree in chemistry from the University of Mississippi, where he was an Academic All-American football player. He received his medical degree and his PhD in pharmacology and molecular sciences from Johns Hopkins University, where he continued his post-doctoral training.

Director, Department of Urology, Brady Urological Institute; Urologist-in-Chief, Johns Hopkins Hospital

PhD (pharmacology and molecular sciences): Johns Hopkins University
MD: Johns Hopkins University School of Medicine

Clinical Interests:
Developing and testing methods for predicting the aggressiveness of prostate cancers